IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management III, LLC

Q3 2019 Holdings

Filed 2019-11-13 | 17 holdings | $40.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Axsome Therapeutics Inc(AXSM)COM05464T104$32.6M1,611,32980.5%
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$7.8M2,708,20719.2%
Milestone Pharmaceuticals Inc(MIST)COM59935V107$38.5K2,066,5290.1%
Ra PharmaceuticalsCOM74933V108$15.9K670,3500.0%
10X Genomics Inc.(TXG)COM88025U109$15.1K300,0000.0%
Protagonist Therapeutics Inc(PTGX)COM74366E102$12.9K1,072,3480.0%
La Jolla Pharmaceuticals(LJPC)COM503459604$11.0K1,251,8980.0%
Obseva SACOMH5861P103$9.7K1,159,7890.0%
Kalvista Pharmaceuticals(KALV)COM483497103$7.4K637,8840.0%
Marinus Pharmaceuticals IncCOM56854Q101$3.9K2,516,1640.0%
Tricida Inc(1T7)COM89610F101$2.5K80,3480.0%
Kiniksa Pharmaceuticals LtdCOMG5269C101$2.4K277,1370.0%
Bellerophon Therapeutics(BLPHEUR)COM078771102$1.2K2,417,2270.0%
Radius Health IncCOM750469207$59623,1310.0%
Constellation Pharmaceuticals(CNST)COM210373106$43166,6670.0%
Proteostasis Therapeutics IncCOM74373B109$187221,2670.0%
Prevail Therapeutics IncCOM74140Y101$544,4080.0%